Arbutus Biopharma
|
 | ||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Re: New President & CEO at Arbutus Bio Viiv healthcare (where Mr. Collier served as president): 76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi. Has a significant market share of the HIV market.
|
||||||||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 34639 | Re: New President & CEO at Arbutus Bio | The Rooster | 0 | 6/17/2019 10:30:22 AM |
